Literature DB >> 19505761

Sigma-1 receptors regulate activity-induced spinal sensitization and neuropathic pain after peripheral nerve injury.

Beatriz de la Puente1, Xavier Nadal, Enrique Portillo-Salido, Ricard Sánchez-Arroyos, Sergio Ovalle, Gabriel Palacios, Asunción Muro, Luz Romero, José Manuel Entrena, José Manuel Baeyens, José Antonio López-García, Rafael Maldonado, Daniel Zamanillo, José Miguel Vela.   

Abstract

Sigma-1 receptor (sigma(1)R) is expressed in key CNS areas involved in nociceptive processing but only limited information is available about its functional role. In the present study we investigated the relevance of sigma(1)R in modulating nerve injury-evoked pain. For this purpose, wild-type mice and mice lacking the sigma(1)R gene were exposed to partial sciatic nerve ligation and neuropathic pain-related behaviors were investigated. To explore underlying mechanisms, spinal processing of repetitive nociceptive stimulation and expression of extracellular signal-regulated kinase (ERK) were also investigated. Sensitivity to noxious heat of homozygous sigma(1)R knockout mice did not differ from wild-type mice. Baseline values obtained in sigma(1)R knockout mice before nerve injury in the plantar, cold-plate and von Frey tests were also indistinguishable from those obtained in wild-type mice. However, cold and mechanical allodynia did not develop in sigma(1)R null mice exposed to partial sciatic nerve injury. Using isolated spinal cords we found that mice lacking sigma(1)R showed reduced wind-up responses respect to wild-type mice, as evidenced by a reduced number of action potentials induced by trains of C-fiber intensity stimuli. In addition, in contrast to wild-type mice, sigma(1)R knockout mice did not show increased phosphorylation of ERK in the spinal cord after sciatic nerve injury. Both wind-up and ERK activation have been related to mechanisms of spinal cord sensitization. Our findings identify sigma(1)R as a constituent of the mechanisms modulating activity-induced sensitization in pain pathways and point to sigma(1)R as a new potential target for drugs designed to alleviate neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19505761     DOI: 10.1016/j.pain.2009.05.013

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  47 in total

1.  Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization.

Authors:  L Romero; D Zamanillo; X Nadal; R Sánchez-Arroyos; I Rivera-Arconada; A Dordal; A Montero; A Muro; A Bura; C Segalés; M Laloya; E Hernández; E Portillo-Salido; M Escriche; X Codony; G Encina; J Burgueño; M Merlos; J M Baeyens; J Giraldo; J A López-García; R Maldonado; C R Plata-Salamán; J M Vela
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

2.  Safety, tolerability and pharmacokinetics of single and multiple doses of a novel sigma-1 receptor antagonist in three randomized phase I studies.

Authors:  Montserrat Abadias; Marisol Escriche; Anna Vaqué; Mariano Sust; Gregorio Encina
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

3.  σ1 receptors activate astrocytes via p38 MAPK phosphorylation leading to the development of mechanical allodynia in a mouse model of neuropathic pain.

Authors:  J Y Moon; D H Roh; S Y Yoon; S R Choi; S G Kwon; H S Choi; S Y Kang; H J Han; A J Beitz; S B Oh; J H Lee
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

Review 4.  Sigma-1 receptor and inflammatory pain.

Authors:  Georgia Gris; Enrique José Cobos; Daniel Zamanillo; Enrique Portillo-Salido
Journal:  Inflamm Res       Date:  2015-04-23       Impact factor: 4.575

5.  Late-onset inner retinal dysfunction in mice lacking sigma receptor 1 (σR1).

Authors:  Yonju Ha; Alan Saul; Amany Tawfik; Cory Williams; Kathryn Bollinger; Robert Smith; Masanori Tachikawa; Eric Zorrilla; Vadivel Ganapathy; Sylvia B Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

6.  Sigma-1 receptor inhibition reverses acute inflammatory hyperalgesia in mice: role of peripheral sigma-1 receptors.

Authors:  M A Tejada; A Montilla-García; C Sánchez-Fernández; J M Entrena; G Perazzoli; J M Baeyens; E J Cobos
Journal:  Psychopharmacology (Berl)       Date:  2014-03-18       Impact factor: 4.530

7.  Evaluation of σ-1 receptor radioligand 18F-FTC-146 in rats and squirrel monkeys using PET.

Authors:  Michelle L James; Bin Shen; Carsten H Nielsen; Deepak Behera; Christine L Buckmaster; Christophe Mesangeau; Cristina Zavaleta; Pradeep K Vuppala; Seshulatha Jamalapuram; Bonnie A Avery; David M Lyons; Christopher R McCurdy; Sandip Biswal; Sanjiv S Gambhir; Frederick T Chin
Journal:  J Nucl Med       Date:  2013-12-12       Impact factor: 10.057

Review 8.  Potential role of nitric oxide synthase isoforms in pathophysiology of neuropathic pain.

Authors:  Abhilasha Ahlawat; Ajay Rana; Nidhi Goyal; Saurabh Sharma
Journal:  Inflammopharmacology       Date:  2014-08-06       Impact factor: 4.473

9.  Selective activation of metabotropic glutamate receptor 7 blocks paclitaxel-induced acute neuropathic pain and suppresses spinal glial reactivity in rats.

Authors:  Jiali Wang; Changyu Jiang; Xiyuan Ba; Shimin Yang; Jiaman Wu; Zelin Huang; Guangyi Jin; Yue Hao
Journal:  Psychopharmacology (Berl)       Date:  2020-10-22       Impact factor: 4.530

10.  Structure activity relationship study of benzo[d]thiazol-2(3H)one based σ receptor ligands.

Authors:  Rohit Bhat; James A Fishback; Rae R Matsumoto; Jacques H Poupaert; Christopher R McCurdy
Journal:  Bioorg Med Chem Lett       Date:  2013-06-29       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.